The National Eye Institute estimates that as many as 150 million Americans could improve their vision through refractive correction techniques. The condition leads to an inability to focus close to subjects, such as a book while reading. For example, presbyopia occurs in individuals between the ages of 40 and 50. Some refractive errors are also age-related. Refractive errors include myopia or near-sightedness, hyperopia or far-sightedness, and astigmatism, which involves distortions at any distance. Refractive errors are the most common ocular ailment in the country, but the right pair of corrective lenses can fix it. Complications related to diabetes, known as diabetic retinopathy, is another common cause of blindness in the United States.Īll eye conditions do not result in blindness. Age-related issues remain the leading cause of blindness in the United States, including macular degeneration, glaucoma, and cataract. Over 4.2 million people in the country aged 40 years or older qualify as legally blind or live with low vision issues. Several eye disorders and diseases impact Americans. Led by doctors, such as Cameron Javid, MD, the Retina Associates team treats various conditions impacting ocular health and visual acuity. For more information about all Retina Associate trials, please visit .īased in Tucson, Arizona, Retina Associates offers retina specialty care services. Other trials involve drugs for branch retinal vein occlusion (BRVO) primary indeterminate lesions and small choroidal melanoma, to name only a few. Wet AMD provides more treatment options, including dietary changes, drugs, photodynamic therapy injections, and laser treatments. There are no treatments for late-stage dry AMD, making it important to take proactive steps to maintain visual acuity while aging. The condition can progress slowly over time or quickly to the point that individuals can no longer read, drive, or perceive faces.ĭry AMD typically plays out over several years and sometimes impacts only one eye. AMD, categorized as wet or dry, is relatively common in the United States and is the leading cause of vision loss for seniors. A healthy macula allows individuals to experience sharp, clear vision when looking straight ahead. One of the organization’s latest trials involves Opthea’s Opt302, a drug used to treat advanced neovascular age-related macular degeneration (AMD), also known as wet AMD.ĪMD is an ocular disease associated with blurred central vision resulting from age-related damage to the macula. The Retina Associates research department has participated in more than 60 clinical trials over two decades. In addition to treating ocular conditions, such as diabetic retinopathy and various eye cancers, Cameron Javid, MD, and the rest of the Retina Associates medical staff engage in numerous medical trials. Retina Associates is a healthcare organization in Tucson, Arizona, specializing in problems impacting retinal health and functionality.
0 Comments
Leave a Reply. |